389621-83-4 Usage
General Description
4-(Piperidine-1-carbonyl)phenylboronic acid is a chemical compound that belongs to the class of organic compounds known as boronic acids. It encompasses boron, an organoboronic acid moiety, and a phenylpiperidine skeleton. 4-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID is significant in the field of organic chemistry due to its role in the Suzuki reaction, a type of carbon-carbon bonding reaction, where phenylboronic acid and its derivatives function as key components. It's crucial to remember that like other boronic acids, this chemical should be stored properly to prevent its degradation, which can be caused by exposure to air or moisture.
Check Digit Verification of cas no
The CAS Registry Mumber 389621-83-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,9,6,2 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 389621-83:
(8*3)+(7*8)+(6*9)+(5*6)+(4*2)+(3*1)+(2*8)+(1*3)=194
194 % 10 = 4
So 389621-83-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H16BNO3/c15-12(14-8-2-1-3-9-14)10-4-6-11(7-5-10)13(16)17/h4-7,16-17H,1-3,8-9H2
389621-83-4Relevant articles and documents
INHIBITORS OF FATTY ACID AMIDE HYDROLASE
-
Page/Page column 210, (2008/12/05)
The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating FAAH mediated disease, disorder or condition by administering a ther
New phenylpyridylpiperazine compounds
-
Page/Page column 9, (2008/06/13)
A compound selected from those of formula (I): [image] wherein: X represents a C(O) or SO2 group, R1 represents an aryl group or a group NR3R4 wherein R3 and R4 are as defined in the description, R2 represents an alkyl, (C3-C8)cycloalkyl or (C3-C8)cycloalkyl-(C1-C6)alkyl group, its isomers, and addition salts thereof, and medicinal products containing the same which are useful in treating conditions treatable by antagonists of type H3 central histamine receptors.